padeliporfin
Term · Oncology and biomedicine · MLC-T-ONC-015767
A vascular-acting photosensitizer consisting of a water-soluble, palladium-substituted bacteriochlorophyll derivative with potential antineoplastic activity. Upon administration, paldeliporfin is activated locally when the tumor bed is exposed to low-power laser light; reactive oxygen species (ROS) are formed upon activation and ROS-mediated necrosis may occur at the site of interaction between the photosensitizer, light and oxygen. Vascular-targeted photodynamic therapy (VTP) with padeliporfin may allow tumor-site specific cytotoxicity while sparing adjacent normal tissues.
| Identifier | MLC-T-ONC-015767 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | palladium-bacteriochlorophyll derivative WST11 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015767",
"term": "padeliporfin",
"field": "Oncology and biomedicine",
"definition": "A vascular-acting photosensitizer consisting of a water-soluble, palladium-substituted bacteriochlorophyll derivative with potential antineoplastic activity. Upon administration, paldeliporfin is activated locally when the tumor bed is exposed to low-power laser light; reactive oxygen species (ROS) are formed upon activation and ROS-mediated necrosis may occur at the site of interaction between the photosensitizer, light and oxygen. Vascular-targeted photodynamic therapy (VTP) with padeliporfin may allow tumor-site specific cytotoxicity while sparing adjacent normal tissues.",
"synonyms": [
"palladium-bacteriochlorophyll derivative WST11"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/padeliporfin/"
}
Record 12,509 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.